Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Insights into Ebola Virus VP35 and VP24 Interferon inhibitory functions and their initial exploitation as drug targets

Fanunza E, Frau A, Corona A, Tramontano E.

Infect Disord Drug Targets. 2018 Nov 23. doi: 10.2174/1871526519666181123145540. [Epub ahead of print]

PMID:
30468131
2.

Identification of Myricetin as an Ebola Virus VP35-Double-Stranded RNA Interaction Inhibitor through a Novel Fluorescence-Based Assay.

Daino GL, Frau A, Sanna C, Rigano D, Distinto S, Madau V, Esposito F, Fanunza E, Bianco G, Taglialatela-Scafati O, Zinzula L, Maccioni E, Corona A, Tramontano E.

Biochemistry. 2018 Nov 6;57(44):6367-6378. doi: 10.1021/acs.biochem.8b00892. Epub 2018 Oct 22.

PMID:
30298725
3.

Development and Validation of a Novel Dual Luciferase Reporter Gene Assay to Quantify Ebola Virus VP24 Inhibition of IFN Signaling.

Fanunza E, Frau A, Sgarbanti M, Orsatti R, Corona A, Tramontano E.

Viruses. 2018 Feb 24;10(2). pii: E98. doi: 10.3390/v10020098.

4.

Broad-range potential of Asphodelus microcarpus leaves extract for drug development.

Di Petrillo A, Fais A, Pintus F, Santos-Buelga C, González-Paramás AM, Piras V, Orrù G, Mameli A, Tramontano E, Frau A.

BMC Microbiol. 2017 Jul 14;17(1):159. doi: 10.1186/s12866-017-1068-5.

5.

Uvaria angolensis as a promising source of inhibitors of HIV-1 RT-associated RNA-dependent DNA polymerase and RNase H functions.

Ngoutane Mfopa A, Corona A, Eloh K, Tramontano E, Frau A, Boyom FF, Caboni P, Tocco G.

Nat Prod Res. 2018 Mar;32(6):640-647. doi: 10.1080/14786419.2017.1332615. Epub 2017 May 25.

PMID:
28540745
6.

Correction: ISG15 Regulates Peritoneal Macrophages Functionality against Viral Infection.

Yángüez E, García-Culebras A, Frau A, Llompart C, Knobeloch KP, Gutierrez-Erlandsson S, García-Sastre A, Esteban M, Nieto A, Guerra S.

PLoS Pathog. 2016 Oct 13;12(10):e1005969. doi: 10.1371/journal.ppat.1005969. eCollection 2016 Oct.

7.

ISG15 regulates peritoneal macrophages functionality against viral infection.

Yángüez E, García-Culebras A, Frau A, Llompart C, Knobeloch KP, Gutierrez-Erlandsson S, García-Sastre A, Esteban M, Nieto A, Guerra S.

PLoS Pathog. 2013;9(10):e1003632. doi: 10.1371/journal.ppat.1003632. Epub 2013 Oct 10. Erratum in: PLoS Pathog. 2013 Oct;9(10). doi: 10.1371/annotation/64a20cef-bf55-4d84-983e-b914eb09b1ee. PLoS Pathog. 2016 Oct 13;12 (10 ):e1005969.

Supplemental Content

Loading ...
Support Center